Want to see AMWL full AI Analyst Report?
Earnings Data
Report Date
Aug 05, 2026After Close (Confirmed)
Period Ending
2026 (Q2)Consensus EPS Forecast
-0.86Last Year’s EPS
-1.24Same Quarter Last Year
Based on 7 Analysts Ratings
Earnings Call Summary
Earnings Call Sentiment|Positive
The call conveyed balanced but constructive progress: clear operational and cost improvements drove meaningful profitability trajectory (adjusted EBITDA and operating loss improvement), a stronger recurring revenue mix, sizable pipeline expansion, and government/customer validations (Elevance renewal, DHA deployment). Offsetting these positives were continued top-line headwinds—total revenue down ~18%, subscription revenue down ~23%, and total platform visits down ~19%—and the company remains unprofitable on a GAAP basis for 2026. Management's guidance (narrowed adjusted EBITDA loss range), strong cash position, reduced cash burn, and confidence in reaching cash flow breakeven in Q4 2026 tilt the overall tone optimistic despite near-term revenue and usage declines.Company Guidance
Improved Profitability and Operating Performance
Adjusted EBITDA loss improved to -$3.1M in Q1 2026 from -$12.2M in Q1 2025 (a $9.1M improvement). Operating loss improved ~43% year-over-year to -$17.4M from -$30.4M.
Large Reduction in 2025 Losses
Company reduced net loss and adjusted EBITDA losses by approximately $100M in 2025, reflecting significant cost and operating improvements.
Stronger Visit Mix and Higher-Value Care
Amwell Medical Group (AMG) visit revenue was $28.9M, up ~9% year-over-year. AMG paid visits ~382k (slightly up YoY) and revenue per visit rose to ~$76, up ~$5 per visit YoY. Virtual primary care visits increased ~57% YoY.
Subscription Mix and Renewals Momentum
Subscription revenue represented ~53% of total revenue (a larger recurring mix). Renewals and retention in Q1 were higher than budgeted; Elevance Health renewed for three years, a meaningful validation.
Strong Cash Position and Lower Cash Burn
Ended the quarter with $179M in cash and investments (CEO cited $182M earlier), zero debt. Q1 cash burn ~ $3.1M, down from $19M in the prior quarter, underpinning confidence in reaching cash flow breakeven in Q4 2026.
Significant Pipeline Growth and Government Validation
Management reported pipeline is a multiple of last year (CFO indicated closer to triple-digit growth). DHA (Defense Health Agency) deployment and military health system contract extension provide government-scale validation; DHA renewal expected around end of Q2/start of Q3.
Tighter Cost Structure
Total operating expenses decreased ~31% YoY and operating expenses as a percentage of revenue improved to 82.6% from 98.3% in Q1 2025, supporting margin and profitability trajectory.
AMWL Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
AMWL Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
May 05, 2026 | $6.36 | $7.15 | +12.42% |
Feb 12, 2026 | $4.33 | $5.40 | +24.71% |
Nov 04, 2025 | $5.05 | $4.57 | -9.50% |
Aug 05, 2025 | $8.48 | $7.86 | -7.31% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
FAQ
When does American Well Corporation (AMWL) report earnings?
American Well Corporation (AMWL) is schdueled to report earning on Aug 05, 2026, After Close (Confirmed).
What is American Well Corporation (AMWL) earnings time?
American Well Corporation (AMWL) earnings time is at Aug 05, 2026, After Close (Confirmed).
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is AMWL EPS forecast?
AMWL EPS forecast for the fiscal quarter 2026 (Q2) is -0.86.